These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9165557)

  • 1. Aminoglycoside adaptive resistance.
    Karlowsky JA; Zelenitsky SA; Zhanel GG
    Pharmacotherapy; 1997; 17(3):549-55. PubMed ID: 9165557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic in vitro and in vivo activities of ampicillin and aminoglycoside combinations against antibiotic-resistant Pseudomonas aeruginosa strains.
    Elkhouly AE; el-Sokkary MA; el-Emam MA
    Chemioterapia; 1987 Jun; 6(2 Suppl):125-8. PubMed ID: 3151331
    [No Abstract]   [Full Text] [Related]  

  • 3. Altered denA and anr gene expression in aminoglycoside adaptive resistance in Pseudomonas aeruginosa.
    Karlowsky JA; Hoban DJ; Zelenitsky SA; Zhanel GG
    J Antimicrob Chemother; 1997 Sep; 40(3):371-6. PubMed ID: 9338489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the MexXY multidrug efflux pump in moderate aminoglycoside resistance in Pseudomonas aeruginosa isolates from Pseudomonas mastitis.
    Chuanchuen R; Wannaprasat W; Ajariyakhajorn K; Schweizer HP
    Microbiol Immunol; 2008 Aug; 52(8):392-8. PubMed ID: 18667038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options.
    Obritsch MD; Fish DN; MacLaren R; Jung R
    Pharmacotherapy; 2005 Oct; 25(10):1353-64. PubMed ID: 16185180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of pharmacokinetics and pharmacodynamics to optimize antimicrobial treatment of Pseudomonas aeruginosa infections.
    Burgess DS
    Clin Infect Dis; 2005 Feb; 40 Suppl 2():S99-104. PubMed ID: 15712103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vivo impact of the MexXY efflux system on aminoglycoside efficacy in an experimental model of Pseudomonas aeruginosa pneumonia treated with tobramycin.
    Martha B; Croisier D; Durand D; Hocquet D; Plesiat P; Piroth L; Portier H; Chavanet P
    Clin Microbiol Infect; 2006 May; 12(5):426-32. PubMed ID: 16643518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminoglycosides are useful for severe respiratory tract infections.
    Craig WA; Andes D
    Semin Respir Infect; 1997 Dec; 12(4):271-7. PubMed ID: 9436954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model.
    Xiong YQ; Caillon J; Kergueris MF; Drugeon H; Baron D; Potel G; Bayer AS
    Antimicrob Agents Chemother; 1997 Apr; 41(4):823-6. PubMed ID: 9087497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel approach to the eradication of Pseudomonas aeruginosa in an infant with CF after outpatient treatment failure.
    Hayes D; Kanga JF; Anstead MI; Kuhn RJ
    Pediatr Pulmonol; 2008 May; 43(5):511-3. PubMed ID: 18383117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis.
    Zelenitsky SA; Harding GK; Sun S; Ubhi K; Ariano RE
    J Antimicrob Chemother; 2003 Oct; 52(4):668-74. PubMed ID: 12951354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tobramycin--clinical pharmacology and chemotherapy].
    Periti P
    J Chemother; 1996 Jan; 8 Suppl 1():3-30. PubMed ID: 8948764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium.
    Mesaros N; Nordmann P; Plésiat P; Roussel-Delvallez M; Van Eldere J; Glupczynski Y; Van Laethem Y; Jacobs F; Lebecque P; Malfroot A; Tulkens PM; Van Bambeke F
    Clin Microbiol Infect; 2007 Jun; 13(6):560-78. PubMed ID: 17266725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres).
    Dubois V; Arpin C; Dupart V; Scavelli A; Coulange L; André C; Fischer I; Grobost F; Brochet JP; Lagrange I; Dutilh B; Jullin J; Noury P; Larribet G; Quentin C
    J Antimicrob Chemother; 2008 Aug; 62(2):316-23. PubMed ID: 18467306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development?
    Burkhardt O; Lehmann C; Madabushi R; Kumar V; Derendorf H; Welte T
    J Antimicrob Chemother; 2006 Oct; 58(4):822-9. PubMed ID: 16885180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.
    Hassett DJ; Sutton MD; Schurr MJ; Herr AB; Caldwell CC; Matu JO
    Trends Microbiol; 2009 Mar; 17(3):130-8. PubMed ID: 19231190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A comparative study of the effects of aminoglycoside antibiotics].
    Hejzlar M; Kittnar E; Pellar T; Silarová J; Paroubek M; Hájková L; Sedmidubský V; Safránková M; Stastná L; Janatová E
    Cesk Epidemiol Mikrobiol Imunol; 1982 Nov; 31(6):375-82. PubMed ID: 6216968
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
    Hocquet D; Muller A; Blanc K; Plésiat P; Talon D; Monnet DL; Bertrand X
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1173-5. PubMed ID: 18180356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo potency of polymyxin B against IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa.
    Miyajima Y; Hiramatsu K; Mizukami E; Morinaga R; Ishii H; Shirai R; Kishi K; Tokimatsu I; Saikawa T; Kadota J
    Int J Antimicrob Agents; 2008 Nov; 32(5):437-40. PubMed ID: 18715759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.